Abstract
On November 23, 2015, the US Food and Drug Administration (FDA) approved nivolumab for the treatment of metastatic renal cell carcinoma (RCC), thus op......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
